AURX: Nuo Therapeutics, Inc. Stock

by  •  • Comments Off on AURX: Nuo Therapeutics, Inc. Stock

SIC 3841 – Surgical and Medical Instruments and Apparatus

Valuation
Market Cap ($M) 35.11
Enterprise Value ($M) 35.06
Book Value ($M) -0.21
Book Value / Share -0.00
Price / Book -164.80
NCAV ($M) -0.76
NCAV / Share -0.02
Price / NCAV -46.31

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -1.90
Return on Equity (ROE) -7.08

Liquidity (mrq)
Quick Ratio 0.39
Current Ratio 0.47

Balance Sheet (mrq) ($M)
Current Assets 0.60
Assets 1.15
Liabilities 1.36
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 1.37
Operating Income -2.46
Net Income -2.32
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -2.23
Cash from Investing -0.15
Cash from Financing 1.74

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G/A Flynn James E 2.20 -52.99
10-22 13G/A Jacobs Paul Anthony 6.00 12.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-04-30 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2025-04-01 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)

Similar Companies
AHICF – Asahi Intecc Co., Ltd. ARTHQ – Arch Therapeutics, Inc.
ATAO – Altair International Corp. BIOLQ – BIOLASE, Inc.
BLUAF – BlueRiver Acquisition Corp.


Financial data and stock pages provided by
Fintel.io